Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps

Clin Otolaryngol. 2013 Jun;38(3):254-8. doi: 10.1111/coa.12096.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Topical
  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Inflammatory Agents / administration & dosage*
  • Chronic Disease
  • Cohort Studies
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mometasone Furoate
  • Nasal Polyps / complications*
  • Nebulizers and Vaporizers
  • Pregnadienediols / administration & dosage*
  • Rhinitis / complications
  • Rhinitis / drug therapy*
  • Sinusitis / complications
  • Sinusitis / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Pregnadienediols
  • Mometasone Furoate